Rare diseases
Investigational molecules
Locations
Back to Portugal15 clinical trials in Viseu, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PortugalStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
PortugalStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
PortugalStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
PortugalPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
PortugalStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
PortugalStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PortugalStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PortugalStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
PortugalStudy to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease
PortugalStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
PortugalStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
PortugalThe busiest research cities in the country
What the registry says about research in the country
Ongoing studies focusing on innovative treatments for inflammatory bowel diseases, with particular emphasis on managing both Crohn's Disease and Ulcerative Colitis. Research aims to evaluate new therapeutic approaches for patients with moderate to severe symptoms.
These trials explore both induction and maintenance therapy options to improve patient outcomes.
Advanced research into rare cardiac conditions, specifically targeting ATTR Amyloidosis with Cardiomyopathy. Multiple studies are evaluating novel therapeutic agents to enhance functional capacity and quality of life for affected patients.
Research includes comparative studies of different treatment approaches and long-term safety evaluations.
Comprehensive evaluation of therapeutic efficacy across various treatment modalities, focusing on both immediate response and long-term maintenance strategies. Studies incorporate advanced monitoring techniques and safety assessments.
Research emphasizes measuring clinical remission rates and sustained therapeutic benefits.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
